Ten Years Milestones in Xanthine Oxidase Inhibitors Discovery: Febuxostat-Based Inhibitors Trends, Bifunctional Derivatives, and Automatized Screening Assays

References (75)

1. 1 McManaman, 2002, Structural and Conformational Analysis of the Oxidase to Dehydrogenase Conversion of Xanthine Oxidoreductase [DOI]
2. 2 Hille, 2014, The Mononuclear Molybdenum Enzymes [DOI]
3. 3 Pacher, 2006, Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol [DOI]
4. 4 Ty, 2019, Malaria inflammation by xanthine oxidase-produced reactive oxygen species [DOI]
5. 5 Iwalokun, 2006, Levels and interactions of plasma xanthine oxidase, catalase and liver function parameters in Nigerian children with Plasmodium falciparum infection [DOI]
6. 6 Luchtemberg, 2008, Xanthine oxidase activity in patients with sepsis [DOI]
7. 7 Schmidt, 2019, The impact of xanthine oxidase (XO) on hemolytic diseases [DOI]
8. 8 Hassoun, 1998, Upregulation of Xanthine Oxidase by Lipopolysaccharide, Interleukin-1, and Hypoxia [DOI]
9. 9 Komakia, 2005, Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease’s airways [DOI]
10. 10 Akhigbe, 2021, Codeine exerts cardiorenal injury via upregulation of adenine deaminase/xanthine oxidase and caspase 3 signaling [DOI]
11. 11 Jinnah, 2013, Metabolic disorders of purine metabolism affecting the nervous system [DOI]
12. 12 Bove, 2017, The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function [DOI]
13. 13 Kim, 2015, Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study [DOI]
14. 14 Dawson, 2006, Uric acid and xanthine oxidase: Future therapeutic targets in the prevention of cardiovascular disease? [DOI]
15. 15 Saito, 2021, Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease [DOI]
16. 16 Borges, 2002, Progress Towards the Discovery of Xanthine Oxidase Inhibitors [DOI]
17. 17 Wright, 1994, Interactions of Oxygen Radicals with Airvvay Epithelium
18. 18 Hyspler, 2009, Antioxidants and vitamins in clinical conditions
19. 19 Copeland, 2007, Targeting enzyme inhibitors in drug discovery [DOI]
20. 20 Cardoso, 2019, Solid-Supported Proteins in the Liquid Chromatography Domain to Probe Ligand-Target Interactions [DOI]
21. 21 Ximenes, 2022, On-flow magnetic particle activity assay for the screening of human purine nucleoside phosphorylase inhibitors [DOI]
22. 22 Calleri, 2021, Analytical settings for in-flow biocatalytic reaction monitoring [DOI]
23. 23 Wu, 2020, Evaluation of xanthine oxidase inhibitory activity of flavonoids by an on-line capillary electrophoresis-based immobilized enzyme microreactor [DOI]
24. 24 Naldi, 2019, Immobilized Enzyme Reactors: An Overview of Applications in Drug Discovery from 2008 to 2018 [DOI]
25. 25 Kelley, 2004, Binding of Xanthine Oxidase to Glycosaminoglycans Limits Inhibition by Oxypurinol [DOI]
26. 26 Shi, 2018, Design, synthesis and bioevaluation of 2-mercapto-6-phenylpyrimidine-4-carboxylic acid derivatives as potent xanthine oxidase inhibitors [DOI]
27. 27 Komoriya, 1993, Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees [DOI]
28. 28 Osada, 1993, Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents [DOI]
29. 29 Robinson, 2018, Febuxostat for the treatment of hyperuricaemia in gout [DOI]
30. 30 Grewal, 2014, Febuxostat: Drug review and update [DOI]
31. 31 Okamoto, 2003, An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition [DOI]
32. 32 Fukunari, 2004, Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: A potent xanthine oxidoreductase inhibitor with hepatic excretion [DOI]
33. 33 Ishibuchi, 2001, Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors [DOI]
34. 34 Ding, 2015, Synthetic approaches to the 2013 new drugs [DOI]
35. 35 Sato, 2009, Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [DOI]
36. 36 Matsumoto, 2011, FYX-051: A novel and potent hybrid-type inhibitor of xanthine oxidoreductase [DOI]
37. 37 Nishino, 2015, Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout [DOI]
38. 38 Song, 2015, Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors [DOI]
39. 39 Guan, 2014, Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors [DOI]
40. 40 Li, 2017, Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors [DOI]
41. 41 Chen, 2015, Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors [DOI]
42. 42 Shi, 2016, Synthesis and bioevaluation of 2-phenyl-5-methyl-2H-1,2,3-triazole-4-carboxylic acid/carbohydrazide derivatives as potent xanthine oxidase inhibitors [DOI]
43. 43 Zhang, 2017, Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors [DOI]
44. 44 Jyothi, 2022, Microwave-Assisted Synthesis, Characterization, Docking Studies and Molecular Dynamic of Some Novel Phenyl Thiazole Analogs as Xanthine Oxidase Inhibitor [DOI]
45. 45 Zhang, 2022, Discovery of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives as novel xanthine oxidase inhibitors [DOI]
46. 46 Zhang, 2019, Design, synthesis and bioevaluation of 3-oxo-6-aryl-2,3-dihydropyridazine-4-carbohydrazide derivatives as novel xanthine oxidase inhibitors [DOI]
47. 47 Khanna, 2012, Isocytosine-based inhibitors of xanthine oxidase: Design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia [DOI]
48. 48 Bajaj, 2013, Lead optimization of isocytosine-derived xanthine oxidase inhibitors [DOI]
49. 49 Zhang, 2019, Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives [DOI]
50. 50 Zhang, 2019, Design, synthesis and biological evaluation of N-(3-(1H-tetrazol-1-yl)phenyl)isonicotinamide derivatives as novel xanthine oxidase inhibitors [DOI]
51. 51 Zhang, 2017, Design, synthesis and biological evaluation of N-(4-alkoxy-3-cyanophenyl)isonicotinamide/nicotinamide derivatives as novel xanthine oxidase inhibitors [DOI]
52. 52 Zhang, 2018, Design, synthesis and biological evaluation of 1-hydroxy-2-phenyl-4-pyridyl-1H-imidazole derivatives as xanthine oxidase inhibitors [DOI]
53. 53 Zhang, 2017, Design, synthesis, and biological evaluation of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives as xanthine oxidase inhibitors [DOI]
54. 54 Rashad, 2021, Febuxostat-based amides and some derived heterocycles targeting xanthine oxidase and COX inhibition. Synthesis, in vitro and in vivo biological evaluation, molecular modeling and in silico ADMET studies [DOI]
55. 55 Figueiredo, 2018, Trisubstituted barbiturates and thiobarbiturates: Synthesis and biological evaluation as xanthine oxidase inhibitors, antioxidants, antibacterial and anti-proliferative agents [DOI]
56. 56 Jursic, 2001, Preparation of 5-formyl- and 5-acetylbarbituric acids, including the corresponding Schiff bases and phenylhydrazones [DOI]
57. 57 Fu, 2014, Affinity selection-based two-dimensional chromatography coupled with high-performance liquid chromatography-mass spectrometry for discovering xanthine oxidase inhibitors from Radix Salviae Miltiorrhizae [DOI]
58. 58 Tang, 2016, Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C [DOI]
59. 59 Tang, 2018, Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold [DOI]
60. 60 Malik, 2017, In-silico design and ADMET studies of natural compounds as inhibitors of xanthine oxidase (XO) enzyme [DOI]
61. 61 Malik, 2019, Mechanistic approach towards interaction of newly synthesized Hesperidin derivatives against xanthine oxidase [DOI]
62. 62 Narasimhan, 2012, Benzimidazole: A medicinally important heterocyclic moiety [DOI]
63. 63 Shah, 2013, Benzimidazole: A promising pharmacophore [DOI]
64. 64 Nile, 2013, In Vitro Evaluation of Selected Benzimidazole Derivatives as an Antioxidant and Xanthine Oxidase Inhibitors [DOI]
65. 65 Hou, 2020, Recent advances in screening active components from natural products based on bioaffinity techniques [DOI]
66. 66 Nie, 2009, Immobilized Enzyme Reactor in On-line LC and Its Application in Drug Screening [DOI]
67. 67 Temporini, 2014, Evaluation of capillary chromatographic supports for immobilized human purine nucleoside phosphorylase in frontal affinity chromatography studies [DOI]
68. 68 Guo, 2019, Recent advances in bio-affinity chromatography for screening bioactive compounds from natural products [DOI]
69. 69 Cardoso, 2016, Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays [DOI]
70. 70 Rodrigues, 2020, On-Flow LC-MS/MS method for screening of xanthine oxidase inhibitors [DOI]
71. 71 Rodrigues, 2015, Characterization and screening of tight binding inhibitors of xanthine oxidase: An on-flow assay [DOI]
72. 72 Rodrigues, 2016, 9-Benzoyl 9-deazaguanines as potent xanthine oxidase inhibitors [DOI]
73. 73 Peng, 2016, Online coupling solid-phase ligand-fishing with high-performance liquid chromatography-diode array detector-tandem mass spectrometry for rapid screening and identification of xanthine oxidase inhibitors in natural products [DOI]
74. 74 Wang, 2020, Affinity Capillary Electrophoresis: A Critical Review of the Literature from 2018 to 2020 [DOI]
75. 75 Lin, 2013, Preparation of a dual-enzyme co-immobilized capillary microreactor and simultaneous screening of multiple enzyme inhibitors by capillary electrophoresis [DOI]

Cited by 15

Showing 9 of 15 known citations — external sources report more than can currently be individually listed.

Related research

• A Novel Catalytic Synthesis of Flavones under Autoclave Conditions and Comparative Study of Anti-cancer Activity — shares topic coverage
• Thermostability and in-vitro Antibacterial Activity of Aqueous Extracts of Tetrapleura tetraptera Pods on Multidrug Resistant Clinical Isolates — shares topic coverage
• Acute Toxicity, Phytochemistry and Anti-diarrheal Effects of Celtis integrifolia Lam. Aqueous Leaf Extract in Wistar Albino Rats — shares topic coverage
• Understanding the Reactivity of Trimethylsilyldiazoalkanes Participating in [3+2] Cycloaddition Reactions towards Diethylfumarate with a Molecular Electron Density Theory Perspective — shares topic coverage
• Understanding the Origin of the Regioselectivity in Non-Polar [3+2] Cycloaddition Reactions through the Molecular Electron Density Theory — shares topic coverage